Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
by Russell, T.W. et al
3rd September 2025 •
comment
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines
by Murray, Sam et al
29th August 2025 •
comment
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study
by Kwesi-Maliepaard, E.M et al
28th May 2025 •
comment
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
by Jerry C. H. Tam, et al.
9th May 2025 •
comment
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic
by Wilhelm Furnon et al.
21st February 2025 •
comment
Estimating Population Immunity to SARS-CoV-2 by Random Sampling from Primary and Secondary Healthcare
by Sam Scott et al.
21st February 2025 •
comment
Open Letter: Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
by Le Nguyen Truc Nhu et al.
14th August 2024 •
comment
Submit an article
We welcome contributions from members. Please submit an article for review by our editorial team.
Upload nowCategories
- biomedical research (1)
- Community Engagement (1)
- Connect (1)
- Coronavirus (7)
- COVID (4)
- COVID-19 (WEPHREN Resources) (3)
- Latest Publications (1)
- Latin America (1)
- Microbiology (1)
- pathogen variants (15)
- Pathogen Variants Network (1)
- Public Engagement (Mesh) (1)
- SARS-CoV2 (7)
- Southeast Asia (Mesh) (1)
- Vacccine Production (1)